SOLICITATION NOTICE
66 -- Water System
- Notice Date
- 8/4/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 333298
— All Other Industrial Machinery Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-09-1060109
- Point of Contact
- Karen R. Petty, Phone: 301-827-8774
- E-Mail Address
-
karen.petty@fda.hhs.gov
(karen.petty@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Synopsis: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6. This announcement constitutes the only solicitation and a written solicitation will not be issued. This synopsis, NAICS code 334516, is to notify contractors that the Food and Drug Administration (FDA) is seeking competition of this requirement in accordance with FAR Part 13.106 for the following statement of work, under the simplified acquisition procures. Under the simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-35. This synopsis is designated for 100% Small Business Set Aside competition for a firm fixed-price purchase order. Prospective offerors are responsible for monitoring the FedBizOpps website for the release of any amendments to this solicitation. Hard copies will be provided to individuals eligible under the Americans with Disabilities Act and Rehabilitation Act upon request. This combined synopsis solicitation is issued as a Request for Quotations (RFQ). The FDA intends to award a purchase order for a Water System. The Office of Research will purchase a new laboratory water delivery system to replace a 14 year old system. Required specifications: The system must include the following components and meet these exact specifications: 1.The units must be able to be mounted on a wall, or to stand on a bench-top for ease of use for shorter scientists. 2.The units must have point-of-use filter delivery devices that allow for the further purification of the dispensed water. 3.The units must have a bench-integrated system for delivery of the water at remote locations, through a point-of-use filter. 4.The dispensing arm must be able to be removed from the arm, and the water flow must be activated through the point-of-use arm without returning to the filter housing unit. 5.The units must be able to be up-graded with different filters that will improve the water quality produced without the purchase of a whole new unit and system. That improvement through filter change can occur with the change of the point-of-use filter, (i.e. to a BioPak filter), or through the change of the large filter in the unit housing. The change of filter would then eliminate contaminants that are now compromising the results of testing that is being performed in the laboratory. 6.The maintenance of the units, and the changing of filters. 7.Minimum routine maintenance of the units is preferred as the long range cost of consumables can be excessively expensive. 8.The units must be nearly silent during their periodic re-cycling of water through the filter throughout the day, as these units are located in the laboratory where employees are working. Loud squealing of the mechanism can be distracting and annoying to lab personnel. EVALUATION AND AWARD: Award will be made to the party whose quote offers the best value to the Government, technical, price, and other factors considered. The Government may award this purchase order to other than the lowest price technically acceptable quote. The Government will evaluate information based on the following evaluation criteria: 1) Technical Capability factor "Meeting or Exceeding the Requirement," and 2) Price-- price warranty to include four (4) option years. Technical Capability is significantly more important than price. The FDA intends to make an award immediately after the response date of this notice. The award will be made in accordance with FAR Part 13, Simplified Acquisition Procedures. Place of Performance: Food and Drug Administration 8401 Muirkirk Road Laurel, MD 20708 It is the responsibility of the contractor to be familiar with the applicable clauses and provisions. The clauses may be accessed in full text at these addresses: www.acqnet.gov. The provision 52.212-1, Instructions to Offerors-Commercial applies to this acquisition. Offerors should complete their representations and certifications at Online Representations and Certifications Application (ORCA) at http://orca.bpn.gov. The Food and Drug Administration requests responses from qualified sources capable of providing these services in accordance with the attached. FAR provision 52.212-2, Evaluation-Commercial Items applies. FAR Provision, 52.212-3, Offeror Representations and Certifications applies, if the contractor is not registered in ORCA, the vendor shall complete and submit with offer. FAR Clauses 52.212-4 and 52.212-5 apply. The FAR clauses cited in the clause are applicable to this acquisition: 52.219-28, 52.222-3, 52.222-21, 52.222-26, 52.222-36, 52.222-36, 52.222-50, 52.225-13, 52.232-33, and 52.239-1. Government reserves the right to award a purchase order without discussion if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. The total number of pages for the technical plan is not expected to exceed twenty (20) pages in length CCR: Vendors must be registered in the Central Contractor Register (CCR) prior to the award of a contract. You may register by going to www.ccr.gov. All questions are to be submitted via email to karen.petty@fda.hhs.gov no later than August 7, 2009 10:00 AM EST. NO PHONE CALLS WILL BE ACCEPTED. This is a REQUEST FOR QUOTATION (RFQ). This announcement constitutes the only solicitation and a written solicitation will not be issued. All quotations are due, via email to: karen.petty@fda.hhs.gov no later than 4:30pm, EST on August 13, 2009. FDA anticipates an award soon after the response date.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-09-1060109/listing.html)
- Place of Performance
- Address: 8401 Muirkirk Rd, Laurel, Maryland, 20708, United States
- Zip Code: 20708
- Zip Code: 20708
- Record
- SN01899445-W 20090806/090805001235-695b2108e8eea0b55a42ba69011542e5 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |